Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis

Wiener Klinische Wochenschrift

Volumn 126, Issue 11-12, 2014, Pages 341-346

  Savas, Esen ^a   Aksoy, Nur ^a   Pehlivan, Yavuz ^a   Sayiner, Zeynel Abidin ^a   Öztürk, Zeynel Abidin ^a   Tabur, Suzan ^a   Örkmez, Mustafa ^a   Onat, Ahmet Mesut ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Gastrointestinal tract; Lung; Prolidase; Scleroderma; Total oxidant status

Indexed keywords

PROLINE DIPEPTIDASE; ANTIOXIDANT; BIOLOGICAL MARKER; DIPEPTIDASE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EVALUATION STUDY; FEMALE; FIBROBLAST; GASTROINTESTINAL TRACT; HUMAN; LUNG; MALE; METABOLIC PARAMETERS; OXIDATIVE STRESS; SYSTEMIC SCLEROSIS; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; BLOOD; CONTROLLED CLINICAL TRIAL; METABOLISM; MIDDLE AGED; REPRODUCIBILITY; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

ANTIOXIDANTS; BIOLOGICAL MARKERS; DIPEPTIDASES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; OXIDANTS; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 84903706415     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-014-0534-4     Document Type: Article

References (35)

1. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587-95. (Pubitemid 41726446)
2. Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV. Oxidative stress and the pathogenesis of scleroderma: the Murrel's hypothesis revisited. Semin Immunopathol. 2008;30:329-37.
3. Murrell GAC, Francis MJO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265:659-65. (Pubitemid 20053867)
4. Hinchcliff M, Varga J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician. 2008;78:961-8.
5. Eckes B, Mauch C, Huppe G, Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J. 1996;315:549-54. (Pubitemid 26129506)
6. Myara I, Charpentier C, Lemonnier A. Minireview: prolidase and prolidase deficiency. Life Sci. 1984;34:1985-98.
7. Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 2008;35:731-8.
8. Masi AT, Rodnan GP, Medsger TA, Jr, Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum. 1980;23:581-90. (Pubitemid 10101764)
9. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281-5.
10. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicenter study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60:592-8. (Pubitemid 32493986)
11. Medsger TA, Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159-67. (Pubitemid 29487010)
12. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by praline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta. 1982;125:193-205. (Pubitemid 12002380)
13. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91-5.
14. Erel OA. Novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112-9.
15. Koc S, Aksoy N, Bilinc H, Duygu F, Uysal IO, Ekinci A, et al. Paraoxonase and arylesterase activity and total oxidative/antioxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol. 2011;75:1364-7.
16. Erel OA. New automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103-11.
17. Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol. 2005;100:61-4. (Pubitemid 40487937)
18. Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol. 1998;25(2):314-7. (Pubitemid 28088261)
19. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653-64. (Pubitemid 33049343)
20. Stein CM, Tanner SB, Awad JA, Roberts LJ 2nd, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 1996;39(7):1146-50. (Pubitemid 26240227)
21. Herrick AL, Matucci CM. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol. 2001;19(1):4-8. Review. (Pubitemid 32203838)
22. Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155(1-3):1-15.
23. Tikly M, Channa K, Theodorou P, Gulumian M. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol. 2006;25(3):320-4.
24. Kalin R, Righi A, Del Rosso A, Bagchi D, Generini S, Cerinic MM, et al. Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radic Res. 2002;36(8):819-25. (Pubitemid 34830814)
25. Ogawa F, Shimizu K, Muroi E, Hara T, Sato S. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clin Rheumatol. 2011;30:921-5.
26. Rosato E, Rossi C, Molinaro I, Giovannetti A, Pisarri S, Salsano F. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study. Int J Immunopathol Pharmacol. 2011;24(3):727-33.
27. Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, et al. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res. 2010;302:27-35.
28. Musellim B, Ikitimur H, Uzun H, Ongen G. The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int. 2006;27(2):163-7. (Pubitemid 46088274)
29. Gabriele S, Alberto P, Sergio G, Fernanda F, Marco MC. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155:1-15. (Pubitemid 32056309)
30. Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K. Probucol improves symptoms and reduces lipo-protein oxidation susceptibility in patients with Raynaud's phenomenon. Rheumatology (Oxford). 1999;38(4):309-15. (Pubitemid 29507178)
31. Ocakci A, Coskun O, Tumkaya L, Kanter M, Gurel A, Hosnuterd M, et al. Beneficial effects of ebselen on corrosive esophageal burns of rats. Int J Pediatr Otorhinolaryngol. 2006;70(1):45-52. (Pubitemid 41820917)
32. Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339-44. (Pubitemid 46122276)
33. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19(5):319-25.
34. Shrinath M, Walter JH, Haeney M, Couriel J, Lewis M, Herrick A. Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child. 1997;76(5):441-4. (Pubitemid 27261862)
35. Langberg H, Skovgaard D, Asp S, Kjaer M. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif Tissue Int. 2000;67(1):41-4. (Pubitemid 30460947)